Recently genome-wide screening studies to identify frequently mutated genes in lung cancer (e.g., STK11, LRP1B, LPHN3) have provided an exciting new insight into the discovery of potentially novel gene candidates for lung cancer in addition to TP53 and KRAS [54,68]. The gene discussed is TP53; the disease is lung cancer.